Friday, April 27, 2018
Researchers at Kanazawa University report in Cell Stem Cell how the Spred1 molecule is involved in hematopoietic stem cell self-renewal. Experiments with mouse models show that under normal conditions, Spred1 acts as a negative regulator, while under diet-induced stress, it protects hematopoietic homeostasis.
The production of blood cells is regulated by so-called hematopoietic stem cells (HSCs), which reside in bone marrow. It is known that under certain stress conditions, such as aging or inflammation, the HSCs' self-renewal capacity - a key property of stem cells - decreases. Now, a team of researchers led by Yuko Tadokoro and Atsushi Hirao from Kanazawa University have studied the role played by a molecule called Spred1 in the homeostasis (equilibrated self-renewal) of HSCs. Their main finding is that Spred1 safeguards HSC homeostasis in mice subjected to a high-fat diet.
The researchers looked at Spred1 protein because it binds to c-Kit, a molecule involved in signaling processes that govern HSC development and regulation. Experiments with Spred1-deficient mice showed that the protein is not crucial for normal hematopoiesis (the formation of the cellular components of blood) in stress-free situations. Furthermore, Spred1 deficiency promoted HSC self-renewal, resulting in prolonged cellular lifespan, increased competitiveness and better resistance to physiological stress.
Tadokoro and Hirao also used Spred1-dificient mice as a model for Legius syndrome, a pathological condition caused by mutations in the Spred1 gene. They found that Spred1 deficiency does not lead to the development of leukemia, and concluded that the protein is therefore not a conventional tumor suppressor.
In wild-type mice, aging, transplantation and treatment with lipopolysaccharide (a procedure mimicking bacterial infection) upregulated Spred1 protein. The scientists suggest that this upregulation may lead to HSC dysfunction in conditions of physiological stress.
However, when the researchers looked at the effect of a high-fat diet on Spred1-deficient mice, they found that the diet triggered the development of a particular type of blood cancer. This finding clearly demonstrates that Spred1 does play an essential role in regulating hematopoietic homeostasis.
The study of Tadokoro and Hirao highlights the complex relation between Spred1 and hematopoiesis, and establishes a link between the function of the protein and dietary stress. Regarding future research, the scientists conclude that "investigation of the pathophysiological roles of dietary factors in stem cell self-renewal, and exploration of approaches that manipulate Spred1-mediated control of HSC self-renewal, may uncover innovative technologies for preventing diet-related diseases and malignancies."
Hematopoiesis and Spred1
Hematopoiesis is the process of the formation of the cellular components of blood. All blood cellular components are generated from hematopoietic stem cells (HSCs). HSCs reside in bone marrow, and can differentiate into all types of blood cells (red blood cells, lymphocytes and myeloid cells). When they differentiate, some of the produced cells are again HSCs, so there is always a supply of HSCs - the self-renewal process.
Yuko Tadokoro and Atsushi Hirao from Kanazawa University have studied the relationship between a protein called Spred1 (sprouty-related, EVH1 domain-containing protein 1) and the self-renewal of HSCs in mouse models. On the one hand, they found that under normal conditions, Spred1 acts as a negative regulator for HSC self-renewal, while on the other hand, in a situation of diet-induced stress, it safeguards hematopoietic homeostasis.
Legius syndrome is a condition resulting from mutations of the Spred1 gene; symptoms include freckles, learning disabilities and attention-deficit hyperactivity disorder (ADHD). It is often confused with neurofibromatosis type I (NF-1). In the latter, tumor growths are common, whereas in Legius syndrome they are absent.
Tadokoro and Hirao investigated the connection between Spred1 deficiency and Legius syndrome and found that Spred1 does not play the role of a conventional tumor suppressor.
Yuko Tadokoro, Takayuki Hoshii, Satoshi Yamazaki, Koji Eto, Hideo Ema, Masahiko Kobayashi, Masaya Ueno, Kumiko Ohta, Yuriko Arai, Eiji Hara, Kenichi Harada, Masanobu Oshima, Hiroko Oshima, Fumio Arai, Akihiko Yoshimura, Hiromitsu Nakauchi & Atsushi Hirao. Spred1 safeguards hematopoietic homeostasis against diet-induced systemic stress. Cell Stem Cell, Online publication, 26 April 2018.
This work was supported by Japan Society for the Promotion of Science (JSPS), The Ministry of Education, Culture, Sports, Science and Technology (MEXT), World Premier International Research Center Initiative (WPI) from MEXT, Japan Agency for Medical Research and Development (AMED), and Bristol-Myers Squibb.
Division of Molecular Genetics, Cancer Research Institute
Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa, 920-1192, Japan
About WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University
The Kanazawa University Nano Life Science Institute (WPI-NanoLSI) was launched October 2017 following the selection of The University for the World Premier International Research Initiative (WPI) by Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT).
The mission of the NanoLSI is to combine the world's foremost knowledge of bio-scanning probe microscopy and supramolecular chemistry to develop 'nano-endoscopic techniques' to directly image, analyze, and manipulate the nano-dynamics of proteins and nucleic acids both on the surface and inside of living cells. Notably, complementary experimental and multi-scale simulation techniques developed in this research will form a basis for elucidating wide ranging molecular and cellular dynamics by comparing healthy and cancer cells.
Based on the techniques and expertise gained through this process, Kanazawa University will create the new academic field of 'Nanoprobe Life Science', to promote fundamental understanding of critical mechanisms governing diverse life phenomena such as diseases and aging.
About Kanazawa University Cancer Research Institute (KU-CRI)
The Kanazawa University Cancer Research Institute (KU-CRI) bears the distinction of being the only institute solely focused on cancer research amongst the Research Institutes and Centers of Japan National Universities. Since its establishment in 1967, KU-CRI has made numerous groundbreaking contributions to the fields of basic and clinical cancer research.
In 2010, KU-CRI was commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) as a Joint Usage/Research Center on "Metastasis and Drug Resistance". This initiative brings together scientists from diverse fields including natural science, engineering, and clinical therapeutics in forming a cross-discipline alliance against cancer metastasis and drug resistance. With this mandate from the government of Japan, KU-CRI members endeavor to broaden our collaboration nationally and internationally in our battle against cancer.